Abstract 7544: Bromodomain and extra-terminal protein inhibitors deplete nuclear factor 1C and reduce stemness and growth of human small cell lung cancer cells in vitro and in vivo
Haitao Wang(Wuhan University), David S. Schrump(National Institutes of Health), Stephanie Shiffka(National Cancer Institute), Gordon L. Hager(National Institutes of Health), Mary R. Zhang(National Cancer Institute), Frank Echtenkamp(National Cancer Institute), Lyuba Varticovski(National Cancer Institute), Songjoon Baek(National Institutes of Health), Chuong D. Hoang(National Institutes of Health), Frank Villa-Hernandez(National Institutes of Health), Haobin Chen(Washington University in St. Louis), Ruihong Wang(National Institutes of Health), W. Marston Linehan(National Cancer Institute), Razi Raziuddin(National Institutes of Health), Vivek Shukla(National Institutes of Health), Shamus R. Carr(National Institutes of Health), Leonard Μ. Neckers(National Cancer Institute), Sudheer Kumar Gara(National Cancer Center)
Cited by 0
Related Papers
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics
|Breast Cancer Research|2008|660
Transcription Factor AP1 Potentiates Chromatin Accessibility and Glucocorticoid Receptor Binding
|Molecular Cell|2011|499
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|1999|497